My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 10 691 / DOI: 10.3332/ecancer.2016.691

Conference Report

Cancer Immunotherapy: from the lab to clinical applications. Potential impact on cancer centres’ organisation

This report covers the Immunotherapy sessions of the 2016 Organisation of European Cancer Institutes (OECI) Oncology Days meeting, which was held on 15th–17th June 2016 in Brussels, Belgium. Immunotherapy is a potential cancer treatment that uses an individual’s immune system to fight the tumour. In recent years significant advances have been made in this field in the treatment of several advanced cancers. Cancer immunotherapies include monoclonal antibodies that are designed to attack a very specific part of the cancer cell and immune checkpoint inhibitors which are molecules that stimulate or block the inhibition of the immune system. Other cancer immunotherapies include vaccines and T cell infusions. This report will summarise some of the research that is going on in this field and will give us an update on where we are at present.

Keywords: Immunotherapy, monoclonal antibodies, cancer vaccines

Loading Article Metrics ... Please wait

Related articles

Research: Brain imaging before primary lung cancer resection: a controversial topic

Abstract | Full Article | PDF Published: 20 Jun 2017 / DOI: 10.3332/ecancer.2017.749

Research: Immunohistochemical expression of ER-α and PR in papillary thyroid carcinoma

Abstract | Full Article | PDF Published: 13 Jun 2017 / DOI: 10.3332/ecancer.2017.748

Special Issue: The molecular understanding of cancer: from the unspeakable illness to a curable disease

Abstract | Full Article | PDF Published: 08 Jun 2017 / DOI: 10.3332/ecancer.2017.747

Special Issue: The past and future of breast cancer treatment—from the papyrus to individualised treatment approaches

Abstract | Full Article | PDF Published: 08 Jun 2017 / DOI: 10.3332/ecancer.2017.746

Special Issue: Radioguided localisation of non-palpable lesions of the breast in Costa Rica: Review of results of our first 800 patients in private practice

Abstract | Full Article | PDF | Spanish Published: 08 Jun 2017 / DOI: 10.3332/ecancer.2017.745



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence